Neurotoxicity of carbapenem compounds and other beta-lactam antibiotics

Japanese Journal of Antibiotics

Volumn 49, Issue 1, 1996, Pages 13-16

  Sunagawa, Makoto ^a   Nouda, Hiroshi ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BETA LACTAM ANTIBIOTIC; BETAMIPRON; BIAPENEM; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CILASTATIN; IMIPENEM; MEROPENEM; PANIPENEM; PENICILLIN G; PENICILLINASE; PENTETRAZOLE; PROBENECID; THIENAMYCIN;

BLOOD BRAIN BARRIER; CONVULSION; DOSE RESPONSE; DRUG PENETRATION; DRUG STRUCTURE; INTRAVENOUS DRUG ADMINISTRATION; NEUROTOXICITY; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BRAIN; CARBAPENEMS;

EID: 0030034054     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. SCHNEIDER, C. H. & A. L. DE WECK: Allergy towards β-lactam antibiotics. In "Beta-Lactam Antibiotics", Ed. by S. MITSUHASHI, Japan Scientific Societies Press, Tokyo, pp. 299-316, 1981
2. FOORD, R. D: Cephaloridine, cephalothin and the kidney. J. Antimicrob. Chemother. 1 (Suppl.): 119-133, 1975
3. BARTLETT, J. G.; S. H. WILLEY, T. W. CHANG & B. LOWE: Cephalosporin-associated pseudomembranous colitis due to Clostridium difficile. J. Am. Med. Assoc. 242: 2683-2685, 1979
4. WEINSTEIN, L.; P. I. LERNER & W. H. CHEW: Clinical and bacteriologic studies of the effect of "massive" doses of penicillin G on infections caused by Gram-negative bacilli. New Engl. J. Med. 271: 531-532, 1964
5. SCHLIAMSER, S. E.; O. CARS & S. R. NORRBY: Neurotoxicity of β-lactam antibiotics: predisposing factors and pathogenesis. J. Antimicrob. Chemother. 27: 405-425, 1991
6. FOSSIECK, B. Jr. & R. H. PARKER: Neurotoxicity during intravenous infusion of penicillin. A review. J. Clin. Pharmacol. 14: 504-512, 1974
7. HORI, S.; S. KURIOKA, M. MATSUDA & J. SHIMADA: Inhibitory effect of cephalosporins on γ-aminobutyric acid receptor binding in rat synaptic membranes. Antimicrob. Agents. Chemother. 27: 650-651, 1985
8. GERALD, M. C.; J. MASSEY & D. C. SPADARO: Comparative convulsant activity of various penicillins after intracerebral injection in mice. J. Pharm. Pharmacol. 25: 104-108, 1972
9. WILLIAMS, P. D.; D. B. BENNETT & C. R. COMERESKI: Animal model for evaluating the convulsive liability of β-lactam antibiotics. Antimicrob. Agents Chemother. 32: 758-760, 1988
10. SCHLIAMSER, S. E.; H. BOLANDER, H. KOURTOPOULOS & S. R. NORRBY: Neurotoxicity of benzylpenicillin: correlation to concentrations in serum, cerebrospinal fluid and brain tissue fluid in rabbits. J. Antimicrob. Chemother. 21: 365-372, 1988
11. DE SARRO, A.; G. B. DE SARRO, C. ASCIOTI & G. NISTICO: Epileptogenic activity of some β-lactam derivatives: Structure-activity relationship. Neuropharmacol. 28: 359-365, 1989
12. TSE, C. S. T.; F. HERNANDEZ VERA & D. V. DESAI: Seizure-like activity associated with imipenem-cilastatin. Drug Intel. Clin. Pharm. 21: 659-660, 1987
13. CALANDRA, G.; E. LYDICK, J. CARRIGAN, L. WEISS & H. GUESS: Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastatin. Am. J. Med. 84: 911-918, 1988
14. Chemotherapy 33 (Suppl. 4): S329-S356, 1985
15. Chemotherapy 40 (Suppl. 1): S175-S181, 1992
16. KURIHARA, A.; M. HISAOKA, N. MIKUNI & K. KAMOSHIDA: Neurotoxicity of panipenem/betamipron, a new carbapenem, in rabbits: Correlation to concentration in central nervous system. J. Pharmacobiodyn. 15: 325-332, 1992
17. PATEL, J. B. & R. E. GILES: Meropenem: evidence of lack of proconvulsive tendency in mice. J. Antimicrob. Chemother. 24 (Suppl. A): S307-S309, 1989
18. DAY, I. P.; J. GOUDIE, K. NISHIKI & P. D. WILLIAMS: Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem. Toxicol. Lett. 76: 239-243, 1995
19. SUNAGAWA, M.; H. MATSUMURA, Y. OHNO, M. NAKAMURA & M. FUKASAWA: Meropenem, a novel 1β-methyl carbapenem with low neurotoxic side-effects: Structure-activity relationship for convulsive liability. 31st Intersci. Conf. Antimicrob. Agents & Chemother.; Abstract No. 167, p. 126, Sept. 29-Oct. 2, 1991 (Chicago)
20. SCHLIAMSER, S. E.; H. BOLANDER, K.-A. BROHOLM, U. GERDES, H. KOURTOPOULOS & S. R. NORRBY: Neurotoxicity of benzylpenicillin in experimental renal failure and Enterobacter cloacae meningitis. J. Antimicrob. Chemother. 24: 215-225, 1989
21. Jap. J. Antibiotics 45: 809-813, 1992
22. SUNAGAWA, M.; H. MATSUMURA, Y. SUMITA & H. NOUDA: Structural features resulting in convulsive activity of carbapenem compounds: Effect of C-2 side chain. J. Antibiotics 48: 408-416, 1995
23. SHIMADA, J.; S. HORI, K. KANEMITSU, Y. SHOJI, S. NAKASHIO & A. YANAGAWA: A comparative study on the convulsant activity of carbapenems and beta-lactams. Drugs Exp. Clin. Res. 18: 377-381, 1992
24. Chemotherapy 42 (Suppl. 4): S115-S119, 1994
25. SUNAGAWA, M.; H. MATSUMURA & M. FUKASAWA: Structure-activity relationships of carbapenem and penem compounds for the convulsive property. J. Antibiotics 45: 1983-1985, 1992
26. SMITH, G. B. & E. F. SCHOENEWALDT: Stability of N-formimidoylthienamycin in aqueous solution. J. Pharm. Sci. 70: 272-276, 1981
27. TAKEUCHI, Y.; M. SUNAGAWA, Y. ISOBE, Y. HAMAZUME & T. NOGUCHI: Stability of a 1β-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution. Chem. Pharm. Bull. 43: 689-692, 1995
28. ANTONIADIS, A.; W. E. MÜLLER & U. WOLLERT: Inhibition of GABA and benzodiazepine receptor binding by penicillins. Neurosci. Lett. 18: 309-312, 1980
29. A receptor shows a ligand-gated receptor super-family. Nature 328: 221-227, 1987
30. MEULEMANS, A.; P. VICART, D. HENZEL, J. MOHLER & M. VULPILLAT: Cefsulodin penetration into rat brain: Extracellular versus total concentration. Chemotherapy (Basel) 32: 393-398, 1986
31. A, benzodiazepine and glycine receptor binding in relation to lack of central nervous system toxicity in rats. Antimicrob. Agents Chemother. 37: 199 -202, 1993
32. DE SARRO, G.; D. AMMENDOLA, F. NAVA & A. DE SARRO: Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice. Brain Res. 671: 131-140, 1995
33. JOHNSON, H. C. & A. E. WALKER: Intraventricular penicillin; a note of warning. J. Am. Med. Assoc. 127: 217-219, 1945
34. KAMEI, C.; K. KITAZUMI, S. TSUJIMOTO, T. YOSHIDA & K. TASAKA: Comparative study of certain antibiotics on epileptogenic property, including (1Rpi, 5S, 6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4] triazolium-6-yl)] thio-6-[(R)-1-hydroxyethyl]-1-methyl-carbapenem-3-carboxylate (LJC10627), a carbapenem antibiotic with broad antimicrobial spectrum. J. Pharmacobiodyn. 14: 509-517, 1991
35. CUTLER, R. W. & J. YOUNG: The effect of penicillin on the release of gamma-aminobutyric acid from cerebral cortex slices. Brain Res. 170: 157-163, 1979
36. DE SARRO, A.; M. ZAPPALA, A. CHIMIRRI, S. GRASSO & G. B. DE SARRO: Quinolones potentiate cefazolin-induced seizures in DBA/2 mice. Antimicrob. Agents Chemother. 37: 1497-1503, 1993
37. DE SARRO, A.; D. AMMENDOLA & G. DE SARRO: Effects of some quinolones on imipenem-induced seizures in DBA/2 mice. Gen. Pharmacol. 25: 369-379, 1994
38. BÖSMÜLLER, C.; W. STEURER, A. KÖNIGSRAINER, J. WILLEIT & R. MARGREITER: Increased risk of central nervous system toxicity in patients treated with ciclosporin and imipenem/cilastatin. Nephron 58: 362-364, 1991
39. SEMEL, J. D. & N. ALLEN: Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole. South. Med. J. 84: 465-468, 1991
40. BIRNBAUM, J.; F.M. KAHAN, H. KROPP & J. S. MACDONALD: Carbapenems, a new class of beta-lactam antibiotics: Discovery and development of imipenem/cilastatin. Am. J. Med. 78(Suppl. 6A): 3-21, 1985
41. Chemotherapy 39 (Suppl. 3): S166-S177, 1991
42. DE SARRO, A.; C. IMPERATORE, P. MASTROENI & G. DE SARRO: Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice. J. Pharm. Pharmacol. 47: 292-296, 1995
43. SUZUKI, H.; Y. SAWADA, Y. SUGIYAMA, T. IGA, M. HANANO & R. SPECTOR: Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system. J. Pharmacol. Exp. Ther. 250: 979-984, 1989